Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform
United European Gastroenterology Journal · 2023
DOI: 10.1002/ueg2.12424 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2023. Verfasst von Tal Engel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Crohn Disease, Crowdsourcing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Internet and social media platforms have become an unprecedented source for sharing self‐experience, potentially allowing the collection and integration of health data with patient experience. StuffThatWorks (STW) is an online open platform that applies machine learning and the power of crowdsourcing, where patients with chronic medical conditions can self‐report and compare their individual outcomes using a structured online questionnaire. We aimed to conduct a cross‐sectional, international, crowdsourcing, artificial‐intelligence (AI) web‐based study of patients with Crohn's disease (CD) self‐reporting their outcomes.
Methods
A proprietary STW Bayesian inference model was built to measure improvement in CD severity (on scale of 1–5) for each treatment and ranked treatments using effectiveness. The effectiveness of first‐line biological treatments was analyzed by multiple comparisons and by calculating odds ratios and 95% confidence intervals for each treatment pair.
Results
We included 7593 self‐reported CD patients for the analysis. Most of the participants were female (75.8%) and from English‐speaking countries (95.7%). Overall, anti‐TNF drugs were the most reported tried treatment (52.8%). Infliximab (IFX) was ranked as the most effective treatment by the STW effectiveness model followed by bowel surgery (second), adalimumab (ADA, third), ustekinumab (UST, 4rd), and vedolizumab (VDZ, fifth). In paired comparison analyses, IFX was most effective, ADA had similar effectiveness compared to UST and all three were more effective than VDZ.
Conclusion
We present the first online crowdsourcing AI platform‐based study of self‐reported treatment effectiveness in CD. Net‐based crowdsourcing patient‐reported outcome platforms can potentially help both clinicians and patients select the best treatment for their condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- StuffThatWorks©, Tel Aviv, Israel.
- Internal Medicine B, Assuta Medical Center, Ashdod, Israel.
- Ben-Gurion University of the Negev, Be'er Sheva, Israel.
ORCID-Profile: Tal Engel, Shelly Soffer, Shomron Ben-Horin, Uri Kopylov
Zitieren
APA
Engel, T., Dotan, E., Synett, Y., Held, R., Soffer, S., Ben-Horin, S., & Kopylov, U. (2023). Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12424
Vancouver
Engel T, Dotan E, Synett Y, Held R, Soffer S, Ben-Horin S, et al. Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform. United European Gastroenterology Journal. 2023. doi:10.1002/ueg2.12424
BibTeX
@article{Engel2023,
author = {Engel, Tal and Dotan, Eran and Synett, Yossi and Held, Ron and Soffer, Shelly and Ben-Horin, Shomron and Kopylov, Uri},
title = {Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform},
journal = {United European Gastroenterology Journal},
year = {2023},
doi = {10.1002/ueg2.12424}
}
EUVIMED